How COVID spawned a surge in superbugs, and what we can do about it

After years of progress in the battle against antimicrobial-resistance, so-called “superbugs” have made a concerning comeback in the age of COVID, with resistant hospital-onset infections and deaths soaring at least 15% in the first year of the pandemic alone, according to a new Centers for Disease Control report. Each year, about 3 million people in […]

Research identifies, exploits vulnerability in certain high-risk cancers

In a study recently published in Cancer Research, a journal of the American Association for Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, sought to expand upon his lab’s previous research that showed ALT tumors […]

How effective is tecovirimat as a treatment against monkeypox?

A recent study published in The New England Journal of Medicine (NEJM) evaluated the use of tecovirimat for monkeypox treatment during the current outbreak. Study: Tecovirimat and the Treatment of Monkeypox — Past, Present, and Future Considerations. Image Credit: Marina Demidiuk/Shutterstock Background Human immunodeficiency virus (HIV) impacted some communities disproportionately in 1988 as it expanded quickly worldwide, […]

Geisinger's telemedicine program shoots from 20 specialties to more than 70

Pennsylvania’s Geisinger health system faces several challenges common to the healthcare industry, such as improving access to care, recruiting and retaining providers, and scaling technologies for rapid deployment across multiple campuses and dozens of medical specialties. THE PROBLEM Serving predominantly rural communities, many of Geisinger’s patients experience barriers to getting the care they need. For […]

Newly designed nanoparticles target the body’s immune cells to turn them against cancer

Scientists of the department of Advanced Organ Bioengineering and Therapeutics (Faculty of S&T, TechMed Centre) recently published a novel cancer immune therapy in the scientific journal Nature Communications. In their research, Prof Dr Jai Prakash and his team developed newly designed nanoparticles which can target the body’s immune cells to turn them against cancer. In […]